# Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit

> **NCT02863809** · PHASE1,PHASE2 · COMPLETED · sponsor: **Joseph B. Ciolino, MD** · enrollment: 76 (actual)

## Conditions studied

- Keratolysis

## Interventions

- **DRUG:** Riboflavin
- **DRUG:** Dextran
- **DEVICE:** UVA Light Source

## Key facts

- **NCT ID:** NCT02863809
- **Lead sponsor:** Joseph B. Ciolino, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-15
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-08-31
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2023-05-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02863809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02863809, "Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02863809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*